Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
139,800
Employees139,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
139,800
Employees139,800

JNJ Key Statistics

Market cap
426.92B
Market cap426.92B
Price-Earnings ratio
19.05
Price-Earnings ratio19.05
Dividend yield
2.85%
Dividend yield2.85%
Average volume
7.66M
Average volume7.66M
High today
$178.32
High today$178.32
Low today
$176.46
Low today$176.46
Open price
$177.88
Open price$177.88
Volume
6.00M
Volume6.00M
52 Week high
$181.16
52 Week high$181.16
52 Week low
$140.68
52 Week low$140.68

JNJ News

Seeking Alpha 8h
Johnson & Johnson gains approval of gemcitabine for local delivery into bladder

Healthcare Johnson & Johnson gains approval of gemcitabine for local delivery into bladder Sep. 09, 2025 5:07 PM ET Johnson & Johnson (JNJ) Stock By: Jonathan B...

Johnson & Johnson gains approval of gemcitabine for local delivery into bladder
TipRanks 9h
Johnson & Johnson announces FDA approval of INLEXZO

Johnson & Johnson announced the U.S. FDA approved INLEXZO, a new, potentially practice-changing approach for treating patients with certain types of bladder can...

TipRanks 19h
Johnson & Johnson Elects John Morikis to Board

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

58%

of 26 ratings
Buy
42.3%
Hold
57.7%
Sell
0%

More JNJ News

Seeking Alpha 21h
Johnson & Johnson appoints former Sherwin-Williams CEO to its board of directors

Johnson & Johnson appoints former Sherwin-Williams CEO to its board of directors Sep. 09, 2025 4:07 AM ET Johnson & Johnson (JNJ) Stock, JNJ:CA Stock By: Meghav...

Johnson & Johnson appoints former Sherwin-Williams CEO to its board of directors
TipRanks 1d
J&J names former Sherwin-Williams CEO to board

Johnson & Johnson (JNJ) announced that John Morikis, retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company (SHW), has been ele...

TipRanks 4d
Nvidia, J&J, JPMorgan, McDonald’s, Roku: Major Stock Sales Unveiled

Insiders have been trading these 5 stocks: ((NVDA)), ((JNJ)), ((JPM)), ((MCD)) and ((ROKU)). Here is a breakdown of their recent trades and their value. Elevate...

TipRanks 4d
Top Executive Sells Massive Stake in Johnson & Johnson!

New insider activity at Johnson & Johnson ( (JNJ) ) has taken place on September 5, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

TipRanks 4d
Johnson & Johnson put volume heavy and directionally bearish

Bearish flow noted in Johnson & Johnson (JNJ) with 16,387 puts trading, or 1.7x expected. Most active are 9/5 weekly 175 puts and 9/5 weekly 180 calls, with tot...

TipRanks 5d
Balanced Outlook on Johnson & Johnson’s MedTech Growth Amid Competitive Challenges

Wells Fargo analyst Larry Biegelsen has maintained their neutral stance on JNJ stock, giving a Hold rating on September 2. Elevate Your Investing Strategy: Take...

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.